Product image of Methotrexate Orion (Methotrexate) supplied by GNH India

Methotrexate Orion

Active Ingredient:
Methotrexate
Origin:
EU

Methotrexate Orion (Methotrexate)

Methotrexate, the active ingredient in Methotrexate Orion, is an antimetabolite (folate antagonist) presented as an oral formulation for oral use. It is employed to modify disease activity in rheumatoid arthritis, manage severe psoriasis, and treat certain cancers such as acute lymphoblastic leukemia and non‑Hodgkin lymphoma.

GNH India supplies Methotrexate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring consistent quality and regulatory compliance. The company adheres to EU GMP standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methotrexate acts on rapidly dividing cells and immune pathways, making it useful across several disease families.

  • Rheumatoid arthritis: reduces joint inflammation and slows structural damage.
  • Psoriasis: limits skin cell proliferation and improves plaque severity.
  • Acute lymphoblastic leukemia: interferes with leukemic cell replication to achieve remission.
  • Non‑Hodgkin lymphoma: hampers malignant lymphocyte growth.
  • Gestational trophoblastic disease: induces regression of trophoblastic tissue.

How It Works

  • Methotrexate inhibits dihydrofolate reductase, preventing the conversion of dihydrofolate to tetrahydrofolate. This blockade reduces the synthesis of purine nucleotides and thymidylate, leading to impaired DNA replication and cell division. The drug also suppresses activation of immune cells, contributing to its anti‑inflammatory and immunomodulatory effects in autoimmune conditions.

Side Effects

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea or vomiting.
  • Fatigue or malaise.
  • Mouth sores or ulceration.
  • Mild liver enzyme elevation.
  • Low white blood cell count.
  • Hair thinning or loss.

Serious or Rare Side Effects

  • Severe liver toxicity or fibrosis.
  • Pulmonary fibrosis or interstitial pneumonitis.
  • Significant bone marrow suppression leading to anemia.
  • Renal impairment or failure.
  • Life‑threatening infections due to immunosuppression.
  • Rare cutaneous reactions such as Stevens‑Johnson syndrome.

Precautions & Warnings

Before initiating therapy, several safety considerations should be observed.

  • Pregnancy: contraindicated (Category X); avoid use in pregnant or planning patients.
  • Liver function: monitor enzymes regularly; adjust if significant elevation occurs.
  • Renal function: assess creatinine clearance; dose may need modification.
  • Hematology: perform complete blood counts to detect marrow suppression.
  • Concomitant folate: supplement with folic acid to reduce mucosal toxicity.
  • Store at ambient temperature: keep below 25°C in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Methotrexate interacts with several drug classes that can alter its efficacy or toxicity.

Major Interactions (Avoid)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal toxicity.
  • Proton pump inhibitors: may raise methotrexate serum levels.
  • Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): potentiate bone marrow suppression.

Moderate Interactions (Monitor Closely)

  • Anticonvulsants (e.g., phenytoin): may reduce methotrexate effectiveness.
  • Vitamin supplements containing folic acid: can diminish therapeutic impact.
  • Live vaccines: increased infection risk; avoid during treatment.

Frequently Asked Questions

Methotrexate Orion is prescribed for rheumatoid arthritis, severe plaque psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, and gestational trophoblastic disease. It works by modulating immune activity and inhibiting the growth of rapidly dividing cells, helping to control inflammation and tumor proliferation.

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate, a cofactor needed for DNA synthesis. By limiting nucleotide formation, it reduces cell replication and suppresses immune cell activation, providing anti‑inflammatory and anticancer effects.

The specific dose of Methotrexate Orion is determined by the prescribing clinician based on the patient’s condition, disease severity, renal and hepatic function, and other individual factors. Only a qualified health professional should set the dosage regimen.

Methotrexate Orion is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal harm. It is also not recommended while breastfeeding because it can be excreted in milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with biologic DMARDs, methotrexate is an oral, small‑molecule agent that is generally less expensive and has a well‑established safety profile. It is often used as first‑line therapy, either alone or in combination with biologics, whereas biologics target specific cytokines and require injection or infusion.

Methotrexate Orion should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Methotrexate Orion is taken orally, usually as a tablet or liquid formulation, according to the prescriber’s instructions. It may be taken with or without food, but consistent administration with respect to meals helps maintain stable absorption.

The most serious risks include severe liver toxicity, pulmonary fibrosis, profound bone‑marrow suppression leading to anemia or infection, and renal failure. Patients should undergo regular laboratory monitoring and report any signs of respiratory difficulty, jaundice, or unusual bleeding promptly.

Methotrexate Orion is contraindicated in pregnant women, individuals planning pregnancy, and those with severe hepatic or renal impairment. It should also be avoided in patients with known hypersensitivity to methotrexate or any of its excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methotrexate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT